NICOLE CROWDER: Open Payments
NPI 1366050981 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,675 in 38 payments from 17 companies in 2025. Trend: 2023 $439 · 2024 $981 · 2025 $1,675
Food & beverage: $1,675
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $400 |
| Novo Nordisk Inc | 7 | $150 |
| Inspire Medical Systems, Inc. | 1 | $139 |
| Gilead Sciences, Inc. | 2 | $138 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| KYOWA KIRIN, INC. | 1 | $122 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| ABIOMED | 1 | $115 |
| ABBVIE INC. | 4 | $78 |
| Exact Sciences Corporation | 2 | $56 |
Products named: AIRSUPRA, BREZTRI, INSPIRE, ZORYVE, Auvelity, Epclusa, Wegovy, UBRELVY.
Industry payments across TX — which companies pay providers there.
